Work

Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model

Year: 2023

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-3108907/v1

Authors: Ram Mahato, Virender Kumar, Bhartu Sethi, Dalton Staller

Institution: University of Nebraska Medical Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Nebraska Medical Center, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism

Awards: G9000119582, Targeting PI3K/BRD4 and Hedgehog Pathway in Alcohol Associated Liver Disease

OpenAlex ID: W4383879244

Cites: 42

Cited by: 2

Related to: 10